Forsinkede kurser. Sist oppdatert: lørdag 20. april  

09/03-2018 12:27:38: (BGBIO) BerGenBio ASA: Extraordinary general meeting

Bergen, Norway, 9 March 2018 - an extraordinary general meeting of BerGenBio ASA
was held in the Company's offices in Jonas Lies vei 91, 5009 Bergen, on 9 March
2018.

All proposals were resolved as presented in the notice convening the
extraordinary general
meeting distributed on 16 February 2018, as further set out in the minutes from
the extraordinary general meeting attached hereto.

For further information, please contact:

Richard Godfrey

CEO, BerGenBio ASA

+47 917 86 304

Rune Skeie 

CFO, BerGenBio ASA

rune.skeie@bergenbio.com

+47 917 86 513

Forward looking statements

This announcement may contain forward-looking statements, which as such are not
historical facts, but are based upon various assumptions, many of which are
based, in turn, upon further assumptions. These assumptions are inherently
subject to significant known and unknown risks, uncertainties and other
important factors. Such risks, uncertainties, contingencies and other important
factors could cause actual events to differ materially from the expectations
expressed or implied in this announcement by such forward-looking statements

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

Ekstern link: http://www.newsweb.no/index.jsp?messageId=446154

Nyheten er levert av OBI.